Your browser doesn't support javascript.
loading
Cardiovascular drug development: is it dead or just hibernating?
Fordyce, Christopher B; Roe, Matthew T; Ahmad, Tariq; Libby, Peter; Borer, Jeffrey S; Hiatt, William R; Bristow, Michael R; Packer, Milton; Wasserman, Scott M; Braunstein, Ned; Pitt, Bertram; DeMets, David L; Cooper-Arnold, Katharine; Armstrong, Paul W; Berkowitz, Scott D; Scott, Rob; Prats, Jayne; Galis, Zorina S; Stockbridge, Norman; Peterson, Eric D; Califf, Robert M.
Afiliação
  • Fordyce CB; Duke Clinical Research Institute, Durham, North Carolina. Electronic address: christopher.fordyce@duke.edu.
  • Roe MT; Duke Clinical Research Institute, Durham, North Carolina.
  • Ahmad T; Duke Clinical Research Institute, Durham, North Carolina.
  • Libby P; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Borer JS; State University of New York Downstate Medical Center, Brooklyn, New York.
  • Hiatt WR; University of Colorado School of Medicine, Aurora, Colorado.
  • Bristow MR; University of Colorado School of Medicine, Aurora, Colorado.
  • Packer M; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Wasserman SM; Amgen, Inc., Thousand Oaks, California.
  • Braunstein N; Regeneron Pharmaceuticals, Tarrytown, New York.
  • Pitt B; University of Michigan School of Medicine, Ann Arbor, Michigan.
  • DeMets DL; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Cooper-Arnold K; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
  • Armstrong PW; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Berkowitz SD; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey.
  • Scott R; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Prats J; The Medicines Company, Parsippany, New Jersey.
  • Galis ZS; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
  • Stockbridge N; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland.
  • Peterson ED; Duke Clinical Research Institute, Durham, North Carolina.
  • Califf RM; Duke Clinical Research Institute, Durham, North Carolina.
J Am Coll Cardiol ; 65(15): 1567-82, 2015 Apr 21.
Article em En | MEDLINE | ID: mdl-25881939
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Descoberta de Drogas Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Descoberta de Drogas Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article